跳至主要内容
临床试验/NCT01900769
NCT01900769已完成不适用

Calculating Blood Volume by Dilution of Hemoglobin - Pilot Study

Kai Schoenhage1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2013年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
matching BV by Hemoglobin dilution (lab)

研究概览

简要总结

Although blood volume is such an important parameter in everyday clinical medicine it cannot be measured easily. As a matter of fact, it is almost never measured but estimated or calculated based upon numbers derived from mostly healthy patients.

The investigators do not even know whether someone's normal - i.e. before a surgery - blood volume is actually anywhere close to the generally accepted estimate or calculation.

Tests exist in which a substance of known concentration is diluted in a person's blood volume and the resulting concentration is then measured, which allows the blood volume to be calculated. However, none of these tests can be completed at the bedside since they are not fast and require considerable set-up.

This study turns the above approach upside-down: we will dilute the blood slightly with a known small volume of an intravenous fluid commonly used in many clinical settings and measure the concentra-tion of hemoglobin - the oxygen carrier contained in red blood cells - before and after adding the fluid. That allows for similar calculations without using neither specialized substances nor equipment.

Hemoglobin is routinely measured in laboratories and is often a routine test before and during surg-eries and in intensive care units.

Devices that can measure hemoglobin through the skin without actually drawing any blood are avail-able. If found comparable to laboratory determination of hemoglobin they could provide for a bedside and almost real-time assessment of blood volume, something that could be extremely valuable for de-cision making in critical areas of medicine and promoting goal directed therapies.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • healthy adults of normal constitution (weight/height)

排除标准

  • any ongoing or recent infusions (< 24h ago) of any fluid/substance
  • morbid obesity
  • heart disease
  • hypertension
  • coagulopathy (bleeding disorder)
  • therapy with anti- or procoagulants
  • transfusion of any blood product
  • therapy with diuretics
  • therapy with vasopressors
  • vasodilators or inotropes
  • acute or chronic infections
  • immunocompromised status
  • hemodynamically unstable
  • hemorrhage (bleeding)
  • recent surgery
  • pregnancy
  • younger than 18 years old

研究组 & 干预措施

Blood Volume Dilution

Experimental

干预措施: Blood Volume Dilution (Drug)

结局指标

主要结局

matching BV by Hemoglobin dilution (lab)

时间窗: 5 - 40 minutes

次要结局

  • matching BV by Hemoglobin dilution (SpHb)(5 - 40 minutes)

研究者

发起方
Kai Schoenhage
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Kai Schoenhage

Assistant Professor, Anesthesiology Director of Perioperative Services, Director of Liver Transplant Anesthesia, Department of Anesthesiology

University of Arizona

研究点 (1)

Loading locations...

相似试验